letter · 2014
Reply to the letters to the editor ‘Differential influence of vemurafenib and dabrafenib on patients' lymphocytes despite similar clinical efficacy in melanoma’ by Schilling et al.
0 citationsDOI: https://doi.org/10.1093/annonc/mdu512Open accessPDF reported by metadataFull text reported by metadata